MedTrace Logo

The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma

NCT01820884 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2024-04-02

No results posted yet for this study

Summary

This randomized trial is studying the efficacy and safety of the hysterectomy alone compared with hysterectomy and bilateral salpingo-oophorectomy (BSO) for patients with Stage IA endometrial carcinoma.

Conditions

  • Endometrial Neoplasms

Interventions

PROCEDURE

TH

Total hysterectomy

PROCEDURE

TH/BSO

Total hysterectomy and bilateral salpingo-oophorectomy

PROCEDURE

BPLND

bilateral pelvic and para-aortic lymph node dissection

Sponsors & Collaborators

  • Shandong University

    collaborator OTHER

  • Huazhong University of Science and Technology

    collaborator OTHER

  • Zhejiang University

    collaborator OTHER

  • Ding Ma

    lead OTHER

Principal Investigators

  • Beihua Kong, MD, PhD · Shandong University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2025-12-31
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01820884 on ClinicalTrials.gov